Cellectar Biosciences Bolsa (NASDAQ: CLRB)

Cellectar Biosciences (NASDAQ:CLRB) Bolsa, Quote.MetaTitle.unusual-options

Cellectar Biosciences

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences Inc

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

BioCardia

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

BioVie

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Edesa Biotech

Ernexa Therapeutics

Evogene

Imunon

Immuron Limited - American Depositary Shares

Immuron

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Marker Therapeutics

Neuphoria Therapeutics Inc. - Common Stock

Neuphoria Therapeutics

OSR Holdings

BiomX

Propanc Biopharma

Palatin Techs

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Soligenix

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

Cellectar Biosciences (CLRB) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Comments

Cellectar Biosciences Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL